{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:42Z","timestamp":1786980102688,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,4]],"date-time":"2013-08-04T00:00:00Z","timestamp":1375574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00403-013-1399-5","type":"journal-article","created":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T11:10:55Z","timestamp":1375528255000},"page":"75-80","source":"Crossref","is-referenced-by-count":46,"title":["Associations between bullous pemphigoid and primary malignant cancers: an English national record linkage study, 1999\u20132011"],"prefix":"10.1007","volume":"306","author":[{"given":"Eugene","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raph","family":"Goldacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uy","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Goldacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,4]]},"reference":[{"issue":"3","key":"1399_CR1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","volume":"132","author":"S Bastuji-Garin","year":"1996","unstructured":"Bastuji-Garin S, Joly P, Picard-Dahan C et al (1996) Drugs associated with bullous pemphigoid: a case-control study. Arch Dermatol 132(3):272\u2013276","journal-title":"Arch Dermatol"},{"key":"1399_CR2","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research, volume II. The design and analysis of cohort studies. International Agency for Research in Cancer, Lyon; IARC Scientific Publication No. 82, pp 103\u2013115"},{"key":"1399_CR3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archderm.1978.01640180094035","volume":"114","author":"TP Chorzelski","year":"1978","unstructured":"Chorzelski TP, Jablonska S, Maciejowska E et al (1978) Co-existence of malignancies with bullous pemphigoid. Arch Dermatol 114:964","journal-title":"Arch Dermatol"},{"key":"1399_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jaad.2010.02.032","volume":"65","author":"M Durdu","year":"2011","unstructured":"Durdu M, Baba M, Se\u00e7kin D (2011) A case of bullous pemphigoid induced by aspirin. J Am Acad Dermatol 65:443\u2013444","journal-title":"J Am Acad Dermatol"},{"key":"1399_CR5","first-page":"42","volume":"32","author":"K Iwashita","year":"2007","unstructured":"Iwashita K, Matsuyama T, Akasaka E et al (2007) The incidence of internal malignancies in autoimmune bullous diseases. Tokai J Exp Clin Med 32:42\u201347","journal-title":"Tokai J Exp Clin Med"},{"key":"1399_CR6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1684\/ejd.2010.0805","volume":"20","author":"H Jedlickova","year":"2010","unstructured":"Jedlickova H, Hlubinka M, Pavlik T et al (2010) Bullous pemphigoid and internal diseases\u2014a case-control study. Eur J Dermatol 20:96\u2013101","journal-title":"Eur J Dermatol"},{"key":"1399_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","volume":"33","author":"M Kasperkiewicz","year":"2007","unstructured":"Kasperkiewicz M, Zillikens D (2007) The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immunol 33:67\u201377","journal-title":"Clin Rev Allergy Immunol"},{"key":"1399_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0190-9622(88)70156-5","volume":"19","author":"VB Laing","year":"1988","unstructured":"Laing VB, Sheretz EF, Flowers FP (1988) Pemphigoid-like bullous eruption related to ibuprofen. J Am Acad Dermatol 19:91\u201394","journal-title":"J Am Acad Dermatol"},{"key":"1399_CR9","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","volume":"337","author":"SM Langan","year":"2008","unstructured":"Langan SM, Smeeth L, Hubbard R et al (2008) Bullous pemphigoid and pemphigus vulgaris\u2014incidence and mortality in the UK: population based cohort study. BMJ 337:a180","journal-title":"BMJ"},{"key":"1399_CR10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2133.2009.09122.x","volume":"160","author":"L Li","year":"2009","unstructured":"Li L, Chen J, Wang B, Yao Y, Zuo Y (2009) Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain. Br J Dermatol 160:1343\u20131345","journal-title":"Br J Dermatol"},{"key":"1399_CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.1990.01670250072011","volume":"126","author":"B Lindelof","year":"1990","unstructured":"Lindelof B, Islam N, Eklund G et al (1990) Pemphigoid and cancer. Arch Dermatol 126:66\u201369","journal-title":"Arch Dermatol"},{"key":"1399_CR12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","volume":"149","author":"A Lloyd-Lavery","year":"2013","unstructured":"Lloyd-Lavery A, Chi C, Wojnarowska F, Taghipour K (2013) The associations between bullous pemphigoid and drug use: a UK case-control study. JAMA Dermatol 149:58\u201362","journal-title":"JAMA Dermatol"},{"key":"1399_CR13","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1345\/aph.1P309","volume":"44","author":"D Mabrouk","year":"2010","unstructured":"Mabrouk D, G\u00fcrcan HM, Keskin DB, Christen WG, Ahmed AR (2010) Association between cancer and immunosuppressive therapy\u2014analysis of selected studies in pemphigus and pemphigoid. Ann Pharmacother 44:1770\u20131776","journal-title":"Ann Pharmacother"},{"issue":"Suppl 1","key":"1399_CR14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000246937","volume":"189","author":"S Morioka","year":"1994","unstructured":"Morioka S, Sakuma M, Ogawa H (1994) The incidence of internal malignancies in autoimmune blistering diseases: pemphigus and bullous pemphigoid in Japan. Dermatology 189(Suppl 1):82\u201384","journal-title":"Dermatology"},{"issue":"6966","key":"1399_CR15","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bmj.309.6966.1411a","volume":"309","author":"PD Mullins","year":"1994","unstructured":"Mullins PD, Choudhury SL (1994) Enalapril and bullous eruptions (case report). BMJ 309(6966):1411","journal-title":"BMJ"},{"key":"1399_CR16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0923-1811(94)00371-K","volume":"9","author":"H Ogawa","year":"1995","unstructured":"Ogawa H, Sakuma M, Morioka S et al (1995) The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci 9:136\u2013141","journal-title":"J Dermatol Sci"},{"key":"1399_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-1","volume":"9","author":"S Ramagopalan","year":"2011","unstructured":"Ramagopalan S, Wotton C, Handel A et al (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 9:1\u20138","journal-title":"BMC Med"},{"key":"1399_CR18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archderm.1975.01630200051003","volume":"111","author":"SP Stone","year":"1975","unstructured":"Stone SP, Schroeter AL (1975) Bullous pemphigoid and associated malignant neoplasms. Arch Dermatol 111:991\u2013994","journal-title":"Arch Dermatol"},{"key":"1399_CR19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2133.1990.tb01447.x","volume":"123","author":"VA Venning","year":"1990","unstructured":"Venning VA, Wojnarowska F (1990) The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol 123:439\u2013445","journal-title":"Br J Dermatol"},{"key":"1399_CR20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0300-483X(02)00612-1","volume":"185","author":"T Vial","year":"2003","unstructured":"Vial T, Descotes J (2003) Immunosuppressive\u00a0drugs and cancer. Toxicology 185:229\u2013240","journal-title":"Toxicology"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-013-1399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-013-1399-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-013-1399-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T07:12:07Z","timestamp":1596265927000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-013-1399-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,4]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1399"],"URL":"https:\/\/doi.org\/10.1007\/s00403-013-1399-5","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,4]]}}}